Source-backed analysis9
Review basis
Research-based review: the AppDuo Editorial Team compiled it from official pages, documentation, app stores, press and user feedback, without hands-on testing. Every claim links to a source with the date it was checked.
9 reference sourcesInformation updated Nov 11, 2026
How we review
Doctronic Review
Free AI health chat, plus $39 video visits with US doctors
By AppDuo Editorial Team · Fact-checked
- Web
- iOS
- Android
On this page
Decide at a glance
Our verdict
A fit for US residents who want a quick symptom check or a prescription renewal at a low flat price. The trade-off: the Utah AI renewal pilot faces objections from the state medical board, and independent evidence on accuracy is thin.
Best for: US residents without insurance who want a flat-price remote visit
Skip it if: Anyone outside the US: the terms require US or US-territory residence
Pros
- Free AI chat, no subscription needed.
- $39 per video visit with a physician licensed in the patient's state.
- Full refund on request for an unsatisfactory telehealth visit (unless insurance paid).
Cons
- The Utah Medical Licensing Board asked for the AI prescription-renewal pilot to be suspended immediately (letter of 20 April 2026).
- Little independent evidence: per TelecareAware, the supporting preprint was written by equity holders; per MedCity News, Mindgard manipulated the chatbot into unsafe dosing advice.
All pros and cons · Who is it for?
More pros
- Trustpilot 4.5/5 from 834 reviews; the company replies to 96% of negative reviews.
More cons
- The Google Play listing says data is never used to train AI, but the privacy policy allows de-identified data to be used for that.
- English only and US residents only; the terms require individual arbitration with a class-action waiver.
Best for
- People who want to talk symptoms through with an AI before booking a visit
Skip it if
- Emergencies or serious pediatric concerns
Experience & key features
What it is
Doctronic Inc. was founded in 2023 and is based in New York, per TelecareAware. The service pairs an AI health chat with video visits with licensed physicians. The homepage says it covers all 50 states and DC; the SOC 2 Type 1 and HIPAA claims are the company's own.
Key features
Users ask the AI about symptoms for free. When needed, they can book a video visit now or later, renew prescriptions and request specialist referrals. The homepage says Doctronic is an AI model, not a licensed doctor, and that its output should be discussed with a doctor. iOS and Android apps are available.
Pricing and value
The AI chat is free. A video visit costs $39 with no subscription, and the homepage says insurance, FSA and HSA are accepted. Patients can request a full refund for an unsatisfactory visit unless insurance paid. There is no dedicated pricing page; prices are spread across the homepage.
More analysis
The Utah renewal debate
Since January 2026 Utah has piloted Doctronic's AI renewing medications a clinician already prescribed. The state Medical Licensing Board objected; state officials replied that every phase-one renewal is physician-approved and the AI may not handle controlled substances. Doctronic says the Utah system differs from the chatbot Mindgard tested.
Who it's for
Compared with general chatbots such as ChatGPT or Gemini, Doctronic adds video visits with real physicians and prescription renewals, but it serves US residents only and is English-only. Its terms do not cover users outside the US.
Screenshots
Plans & pricing
Prices last verified Nov 11, 2026
AI chat
PersonalFree
AI chat about symptoms; the homepage says questions are unlimited.
Video visit
PersonalContact sales
$39 per video visit with a physician licensed in the patient's state, no subscription. The homepage lists prescription renewals "as low as $0".
- Free plan limits
- The AI chat is free; video visits are paid per visit.
- Free trial
- No free trial
Cancellation & refunds
The terms allow a full refund request for an unsatisfactory telehealth visit, except visits paid by insurance. Other payments are nonrefundable unless the terms say otherwise.
Privacy
The privacy policy (updated 9 Oct 2026) lists health information, AI input, approximate IP location and cookie data among what it collects. Doctronic says it does not sell personal information "in the traditional sense", but tracking data shared with advertising partners may count as "selling" or "sharing" under the law; users can opt out by emailing [email protected]. De-identified data, including chat input and output, may be used to train AI models, while the Google Play listing says data is "never" used to train AI. The homepage cites SOC 2 Type 1 and HIPAA compliance.
Doctronic alternatives
7.5/10Gemini
Google's AI assistant, tied into Gmail, Drive, Android and Google storage plans
7.5/10ChatGPT
OpenAI's flagship AI assistant for writing, research, coding, images and voice
Controversies & incidents
Issues documented by the press, regulators, courts or the vendor itself. Every item is sourced; unproven claims are labelled as allegations. Last researched: Nov 11, 2026
- Medium impactAllegedRegulator ·
Utah medical board asks to suspend AI prescription-renewal pilot
Per Fierce Healthcare, 11 of the board's 14 physicians signed a 20 April 2026 letter asking for the pilot to be suspended immediately.
Read the full account
Per Fierce Healthcare, the board said it learned of the agreement only once the system was live, and argued that each renewal needs reassessment by a licensed practitioner. On 21 April, Utah's Office of AI Policy and Division of Professional Licensing replied that the pilot was reviewed by several medical professionals, that in phase one every renewal is physician-approved before reaching a pharmacy, and that the AI is prohibited from handling controlled substances. The board is advisory, and the state plans to continue the pilot. This is the board's position, not a finding by an authority.
Vendor response
A Doctronic spokesperson told Fierce Healthcare the company is participating in the process as designed, with defined safeguards and physician oversight of every prescription in the first phase.
Sources:Fierce Healthcare (2026-04-27)
- Medium impactAllegedMisleading claims ·
Criticism of effectiveness evidence and chatbot safety
Per MedCity News and TelecareAware, security firm Mindgard manipulated Doctronic's chatbot into unsafe dosing guidance, and the published effectiveness evidence has been questioned.
Read the full account
MedCity News (22 March 2026) reported that London-based AI security firm Mindgard jailbroke Doctronic's chatbot with a fabricated "guideline", after which the bot agreed to triple the standard OxyContin dose. TelecareAware (26 March 2026) cites STAT on the same test, and a JAMA Health Forum article (19 March) saying the renewal system apparently had only simulation testing and that the supporting preprint was written by company equity holders and covers the website chatbot, not the renewal system. Analyst Sergei Polevikov questions the "24 million helped" figure. These are criticisms and allegations, not findings by an authority.
Vendor response
Per MedCity News, co-CEO Matt Pavelle said the Utah model is structurally different from the one Mindgard tested because "the AI can only renew what has already been prescribed"; co-CEO Adam Oskowitz said Mindgard uncovered no new risks. Utah's Office of AI Policy said the vulnerabilities do not reflect the system managing prescriptions in the state.
Frequently asked questions
Is Doctronic free?
The AI chat is free. A video visit with a doctor is $39, per the homepage.
Can I use Doctronic outside the US?
The terms require users to be 18+ and live in the US or its territories, so people elsewhere are not covered.
Is Doctronic a real doctor?
The chat is AI. Video visits are with a physician licensed in the patient's state, per the terms.
Does Doctronic use my data to train AI?
The privacy policy allows de-identified data, including chats, to be used to train AI models. The Google Play listing says the opposite, so the privacy policy is the document to check.
Can I get a refund?
The terms allow a full refund request for an unsatisfactory telehealth visit unless insurance paid. Contact support and allow seven business days before filing a chargeback.
Review evidence & sources9
Scores
- Ease of use
- 7.5
- Features
- 7.0
- Value for money
- 8.0
- Performance
- 6.5
- Support
- 6.5
- Privacy & security
- 5.0
Why this score
Simple flow: free AI chat, then a video visit if needed; iOS and Android apps, and an account is optional. English-only interface.
Why this score
Symptom chat, video visits, prescription renewals and specialist referrals. Accuracy evidence comes mainly from a preprint by company equity holders, per TelecareAware.
Why this score
Free AI and $39 per visit with no subscription; insurance, FSA and HSA accepted; refunds available under the terms.
Why this score
The homepage cites an "average wait of about 5 minutes" in one place and "under 30 minutes" in another. Per MedCity News and TelecareAware, Mindgard got the public chatbot to endorse triple the standard OxyContin dose; Doctronic says the Utah system is a different instance.
Why this score
Email only ([email protected]). The company replies to 96% of negative Trustpilot reviews, typically within a week.
Why this score
De-identified data may train AI and tracking data goes to ad partners, at odds with the Google Play listing's statements that data is never used for AI training and not shared with third parties. The homepage cites SOC 2 Type 1 and HIPAA.
What users say
- App Store (US)4.4/5 · 30
- Google Play (US)4.1/5 · 49
- Trustpilot4.5/5 · 834
Sources
- Vendor-providedDoctronic official homepageNov 11, 2026
- Vendor-providedDoctronic Privacy Policy (updated 9 Oct 2026)Nov 11, 2026
- Vendor-providedDoctronic Terms of Service (updated 14 Sep 2026)Nov 11, 2026
- storeApp Store listing (US)Nov 11, 2026
- review-siteTrustpilot reviews of doctronic.aiNov 11, 2026
- pressFierce Healthcare (2026-04-27)Nov 11, 2026
- pressTelecareAware (2026-03-26)Nov 11, 2026
- pressMedCity News (2026-03-22)Nov 11, 2026
- storeGoogle Play listing (US)Nov 11, 2026
Specs & compatibility
Change history
- Update.The Utah Medical Licensing Board sends a letter asking for the pilot to be suspended.
- Company.TelecareAware reports Doctronic raised a $40M Series B.
- Feature.Utah partners with Doctronic to pilot AI renewals of existing prescriptions.
Full change history (5)
- Launch.iOS app version 1.0.0 released on the US App Store.
- Company.Doctronic raises a $20M Series A, per TelecareAware.
About the author
Reviews & comments
Written by readers with a verified email address.
No reviews yet. Have you used Doctronic? Share your real experience.
Reader reviews are counted separately and do not affect the Editorial Team’s score.
No comments yet. Be the first to share your experience.
Comments are readers’ opinions, not content from the AppDuo Editorial Team.